191 related articles for article (PubMed ID: 1186124)
1. Identification of premalignant hyperplasia in methylcholanthrene-induced mammary tumorogenesis.
Fisher ER; Shoemaker RH; Palekar AS
Lab Invest; 1975 Oct; 33(4):446-50. PubMed ID: 1186124
[TBL] [Abstract][Full Text] [Related]
2. Relationship of hyperplasia to cancer in 3-methylcholanthrene-induced mammary tumorogenesis.
Fisher ER; Shoemaker RH; Sabnis A
Lab Invest; 1975 Jul; 33(1):33-42. PubMed ID: 1142740
[TBL] [Abstract][Full Text] [Related]
3. Hyperplastic lesions of mouse mammary glands after treatment with 3-methylcholanthrene.
Faulkin LJ
J Natl Cancer Inst; 1966 Feb; 36(2):289-97. PubMed ID: 4286277
[No Abstract] [Full Text] [Related]
4. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
[TBL] [Abstract][Full Text] [Related]
5. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
Swanson SM; Christov K
Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
[TBL] [Abstract][Full Text] [Related]
6. [Morphology of the collateral mammae in induced mammary carcinoma in BALB/c/Cb/Se mice].
Biancifiori C
Lav Ist Anat Istol Patol Univ Studi Perugia; 1977; 37(1):19-28. PubMed ID: 559894
[No Abstract] [Full Text] [Related]
7. Susceptibility of mammary-tumor-virus-free BALB-c mouse mammary nodule outgrowth cells in DNA synthesis to 3-methylcholanthrene tumorigenesis.
Adamson R; Banerjee MR; Medina D
J Natl Cancer Inst; 1971 Apr; 46(4):899-907. PubMed ID: 5573774
[No Abstract] [Full Text] [Related]
8. Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone.
Grubbs CJ; Farnell DR; Hill DL; McDonough KC
J Natl Cancer Inst; 1985 Apr; 74(4):927-31. PubMed ID: 3857386
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Ting AY; Kimler BF; Fabian CJ; Petroff BK
Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
[TBL] [Abstract][Full Text] [Related]
10. Lack of antigenicity of mammary tumors induced by carcinogens in a nonantigenic preneoplastic lesion.
Halpin ZT; Vaage J; Blair PB
Cancer Res; 1972 Oct; 32(10):2197-200. PubMed ID: 5080764
[No Abstract] [Full Text] [Related]
11. Precancerous morphologic and functional aberrations in the rat mammary glands carcinogenesis.
Joksimović I; Bojanić V; Janćić S; Bojanić Z; Zivanov-Curlis J; Perić S; Janćić S
Gen Physiol Biophys; 2009; 28 Spec No():162-7. PubMed ID: 19893095
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of tamoxifen on the breast cancer risk induced by exogenous estrogen in rat].
Zeng X; Yao Z
Zhonghua Wai Ke Za Zhi; 1996 Mar; 34(3):176-9. PubMed ID: 9387675
[TBL] [Abstract][Full Text] [Related]
13. 4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.
Green A; Shilkaitis A; Christov K
Carcinogenesis; 1999 Aug; 20(8):1535-40. PubMed ID: 10426803
[TBL] [Abstract][Full Text] [Related]
14. Morphology and progression of preneoplastic changes in methylcholanthrene-induced mouse mammary tumorigenesis.
Basolo F; Fontanini G; Squartini F
Tumori; 1985 Feb; 71(1):1-11. PubMed ID: 3984042
[TBL] [Abstract][Full Text] [Related]
15. N-methyl-N-nitrosourea-induced mammary carcinogenesis is promoted by short-term treatment with estrogen and progesterone mimicking pregnancy in aged female Lewis rats.
Tsukamoto R; Mikami T; Miki K; Uehara N; Yuri T; Matsuoka Y; Okazaki K; Tsubura A
Oncol Rep; 2007 Aug; 18(2):337-42. PubMed ID: 17611653
[TBL] [Abstract][Full Text] [Related]
16. Classification of premalignant and malignant lesions developing in the rat mammary gland after injection of sexually immature rats with 1-methyl-1-nitrosourea.
Thompson HJ; Singh M; McGinley J
J Mammary Gland Biol Neoplasia; 2000 Apr; 5(2):201-10. PubMed ID: 11149573
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of androgen and estrogen on the mouse uterus and mammary gland.
Zhang J; Sun Y; Liu Y; Sun Y; Liao DJ
Oncol Rep; 2004 Oct; 12(4):709-16. PubMed ID: 15375489
[TBL] [Abstract][Full Text] [Related]
18. Hormone dependent and independent mammary tumor development form N-methyl-N-nitrosourea-treated rat mammary epithelial cell xenografts in the nude mouse: multiple pathways and H-ras activation.
Hwang SI; Guzman RC; Swanson SM; Nandi S
Cancer Lett; 1996 Mar; 101(1):123-34. PubMed ID: 8625275
[TBL] [Abstract][Full Text] [Related]
19. Effects of exposure of neonatal mice to 17beta-estradiol on subsequent age-incidence and morphology of carcinogen-induced mammary dysplasia.
Warner MR; Warner RL
J Natl Cancer Inst; 1975 Aug; 55(2):289-98. PubMed ID: 808639
[TBL] [Abstract][Full Text] [Related]
20. Rat strain-specific actions of 17beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers.
Harvell DM; Strecker TE; Tochacek M; Xie B; Pennington KL; McComb RD; Roy SK; Shull JD
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2779-84. PubMed ID: 10688907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
